AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today.
Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic.
The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 per share, a year ago. Adjusted net income was $0.6 million, or $0.02 per share.
AngioDynamics expects fiscal year 2021 net sales to be in the range of $278-284 million and adjusted EPS to be $0.00 to $0.05.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a
PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the
With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,